[18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation

Characterization of tau positron emission tomography tracer [ 18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias

(2016) Kerstin Sander et al.   Alzheimers & Dementia

18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers

(2016) Ruben Smith et al.   BRAIN

Regional profiles of the candidate tau PET ligand18F-AV-1451 recapitulate key features of Braak histopathological stages

(2016) Adam J. Schwarz et al.   BRAIN

Tau, amyloid, and hypometabolism in the logopenic variant of primary progressive aphasia

(2016) Belen Pascual et al.   NEUROLOGY

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

(2015) Marta Marquié et al.   ANNALS OF NEUROLOGY

Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy

(2014) Rik Ossenkoppele et al.   ANNALS OF NEUROLOGY

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease

(2013) N. Okamura et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

(2013) Masahiro Maruyama et al.   NEURON

Clinical staging and disease progression in frontotemporal dementia

(2010) E. Mioshi et al.   NEUROLOGY

Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest

(2007) Ioannis S. Gousias et al.   NEUROIMAGE